PANKAJA KASTHURI BREATHE EAZY PLUS SYRUP
PANKAJA KASTHURI BREATHE EAZY PLUS SYRUP : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Piper longum | Piper longum[0.375 gm,15 ml] | Not identified |
| Zingiber officinale | Zingiber officinale[0.188 gm,15 ml] | Not identified |
| Piper nigrum | Piper nigrum[0.088 gm,15 ml] | Not identified |
| Phyllanthus emblica | Phyllanthus emblica[0.075 gm,15 ml] | Not identified |
| Cuminum cyminum | Cuminum cyminum[0.038 gm,15 ml] | Not identified |
| Withania somnifera | Withania somnifera[0.075 gm,15 ml] | Not identified |
| Cedrus deodara | Cedrus deodara[0.100 gm,15 ml] | Not identified |
| Tinospora cordifolia | Tinospora cordifolia[0.188 gm,15 ml] | Not identified |
| Aegle marmelos | Aegle marmelos[0.125 gm,15 ml] | Not identified |
| Adhatoda vasica | Adhatoda vasica[0.125 gm,15 ml] | Not identified |
| Cinnamomum zeylanicum | Cinnamomum zeylanicum[0.063 gm,15 ml] | Not identified |
| Terminalia chebula | Terminalia chebula[0.125 gm,15 ml] | Not identified |
| Hordeum vulgare | Hordeum vulgare[0.250 gm,15 ml] | Not identified |
| Terminalia bellirica | Terminalia bellirica[0.125 gm,15 ml] | Not identified |
| Alpinia galanga | Alpinia galanga[0.188 gm,15 ml] | Not identified |
| Fagonia cretica | Fagonia cretica[0.125 gm,15 ml] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL24066132T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- NATURE SECRET (M) SDN.BHD
- Manufacturer
- Pankajakasthuri Herbals (I) Pvt. Ltd.
- Importer
- NATURE SECRET (M) SDN.BHD
- Registration period starting
- 2024-06-10
- Published validity end
- 2029-06-10
Original register data
View published fields and their variants
- Active ingredients
- Piper longum[0.375 gm,15 ml],Zingiber officinale[0.188 gm,15 ml],Piper nigrum[0.088 gm,15 ml],Phyllanthus emblica[0.075 gm,15 ml],Cuminum cyminum[0.038 gm,15 ml],Withania somnifera[0.075 gm,15 ml],Cedrus deodara[0.100 gm,15 ml],Tinospora cordifolia[0.188 gm,15 ml],Aegle marmelos[0.125 gm,15 ml],Adhatoda vasica[0.125 gm,15 ml],Cinnamomum zeylanicum[0.063 gm,15 ml],Terminalia chebula[0.125 gm,15 ml],Hordeum vulgare[0.250 gm,15 ml],Terminalia bellirica[0.125 gm,15 ml],Alpinia galanga[0.188 gm,15 ml],Fagonia cretica[0.125 gm,15 ml]
- Valid until
- 2029-06-10
- Registration date
- 2024-06-10
- Published description
- NATURAL PRODUCT
- Licence holder
- NATURE SECRET (M) SDN.BHD
- Importer
- NATURE SECRET (M) SDN.BHD
- Producer
- Pankajakasthuri Herbals (I) Pvt. Ltd.
- Published name
- PANKAJA KASTHURI BREATHE EAZY PLUS SYRUP
- Published reference
- 2023112913441T
- Registration number
- MAL24066132T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL24066132T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Phyllanthus emblica
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
Sources cited by Health Canada (3)
- CPhA 2002: Repchinsky C, editor-in-chief. Patient Self-Care: Helping Patients Make Therapeutic Choices. 1st edition. Ottawa (ON): Canadian Pharmacists Association; 2002.
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
- Pray WS. Non-Prescription Product Therapeutics. 2nd edition. New York (NY): Lippincott Williams & Wilkins; 2006.
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
Sources cited by Health Canada (1)
- HC 2009: Laxatives: General - Laxatives - Labelling Standard [Internet]. Ottawa (ON): Drugs and Health Products; Health Canada; 2009. [Accessed 2023 December 31]. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/laxatives-labelling-standards-non-prescription-drugs.html
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- Withania somnifera
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PANKAJA KASTHURI BREATHE EAZY PLUS SYRUP ”, https://compoatlas.com/en/supplements/malaysia/MAL24066132T-pankaja-kasthuri-breathe-eazy-plus-syrup, updated 27 October 2026.